位置:首页 > 蛋白库 > ARNT2_DANRE
ARNT2_DANRE
ID   ARNT2_DANRE             Reviewed;         737 AA.
AC   Q9DG12; Q9DG11; Q9DG13; Q9IAS2;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2006, sequence version 2.
DT   03-AUG-2022, entry version 122.
DE   RecName: Full=Aryl hydrocarbon receptor nuclear translocator 2;
DE            Short=ARNT protein 2;
DE            Short=zfARNT2;
GN   Name=arnt2 {ECO:0000312|ZFIN:ZDB-GENE-001207-3};
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Danionidae; Danioninae; Danio.
OX   NCBI_TaxID=7955;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAG25920.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), FUNCTION, INTERACTION
RP   WITH AHR AND HIF2A, AND TISSUE SPECIFICITY.
RC   TISSUE=Liver {ECO:0000269|PubMed:11072074};
RX   PubMed=11072074; DOI=10.1016/s0167-4781(00)00225-6;
RA   Tanguay R.L., Andreasen E., Heideman W., Peterson R.E.;
RT   "Identification and expression of alternatively spliced aryl hydrocarbon
RT   nuclear translocator 2 (ARNT2) cDNAs from zebrafish with distinct
RT   functions.";
RL   Biochim. Biophys. Acta 1494:117-128(2000).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAF73280.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Embryo {ECO:0000269|PubMed:10960127};
RX   PubMed=10960127; DOI=10.1007/s101260000001;
RA   Wang W.-D., Wu J.-C., Hsu H.-J., Kong Z.-L., Hu C.-H.;
RT   "Overexpression of a zebrafish ARNT2-like factor represses CYP1A
RT   transcription in ZLE cells.";
RL   Mar. Biotechnol. 2:376-386(2000).
CC   -!- FUNCTION: Transcription factor that plays a role in the development of
CC       the hypothalamo-pituitary axis. Specifically recognizes the xenobiotic
CC       response element (XRE) (By similarity). Isoform 1 acts as a
CC       transcriptional activator (PubMed:11072074). Isoform 3 acts as a
CC       transcriptional repressor (PubMed:10960127, PubMed:11072074).
CC       {ECO:0000250|UniProtKB:Q9HBZ2, ECO:0000269|PubMed:10960127,
CC       ECO:0000269|PubMed:11072074}.
CC   -!- SUBUNIT: Efficient DNA binding requires dimerization with another bHLH
CC       protein. Heterodimer with the aryl hydrocarbon receptor (AHR), SIM1 or
CC       HIF2A/EPAS-1. {ECO:0000250|UniProtKB:Q9HBZ2,
CC       ECO:0000269|PubMed:11072074}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000269|PubMed:11072074}; Synonyms=2b
CC       {ECO:0000269|PubMed:11072074};
CC         IsoId=Q9DG12-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:11072074}; Synonyms=2c
CC       {ECO:0000269|PubMed:11072074};
CC         IsoId=Q9DG12-2; Sequence=VSP_052058;
CC       Name=3 {ECO:0000269|PubMed:10960127, ECO:0000269|PubMed:11072074};
CC       Synonyms=2a {ECO:0000269|PubMed:10960127, ECO:0000269|PubMed:11072074};
CC         IsoId=Q9DG12-3; Sequence=VSP_052059, VSP_052060;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are most highly expressed
CC       in the brain, eye and skeletal muscle and to a lower degree in liver,
CC       heart, kidney and swim bladder. Isoform 3 is most highly expressed in
CC       the eye, forebrain, midbrain, hindbrain, skeletal muscle, gills and
CC       brain but is barely detectable in liver, heart, kidney and swim
CC       bladder. Before the pharyngula period isoform 3 is expressed throughout
CC       the entire embryo and during this period extensively in the brain and
CC       eye. {ECO:0000269|PubMed:10960127, ECO:0000269|PubMed:11072074}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF219987; AAG25919.1; -; mRNA.
DR   EMBL; AF219988; AAG25920.1; -; mRNA.
DR   EMBL; AF219989; AAG25921.1; -; mRNA.
DR   EMBL; AF155066; AAF73280.1; -; mRNA.
DR   RefSeq; NP_571749.1; NM_131674.1.
DR   AlphaFoldDB; Q9DG12; -.
DR   SMR; Q9DG12; -.
DR   STRING; 7955.ENSDARP00000110276; -.
DR   PaxDb; Q9DG12; -.
DR   PRIDE; Q9DG12; -.
DR   GeneID; 64277; -.
DR   KEGG; dre:64277; -.
DR   CTD; 9915; -.
DR   ZFIN; ZDB-GENE-001207-3; arnt2.
DR   eggNOG; KOG3561; Eukaryota.
DR   InParanoid; Q9DG12; -.
DR   PhylomeDB; Q9DG12; -.
DR   Reactome; R-DRE-211945; Phase I - Functionalization of compounds.
DR   Reactome; R-DRE-211976; Endogenous sterols.
DR   Reactome; R-DRE-211981; Xenobiotics.
DR   Reactome; R-DRE-8937144; Aryl hydrocarbon receptor signalling.
DR   PRO; PR:Q9DG12; -.
DR   Proteomes; UP000000437; Genome assembly.
DR   Proteomes; UP000814640; Unplaced.
DR   GO; GO:0034751; C:aryl hydrocarbon receptor complex; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005667; C:transcription regulator complex; IEA:InterPro.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; NAS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0007411; P:axon guidance; IMP:ZFIN.
DR   GO; GO:0007420; P:brain development; ISS:UniProtKB.
DR   GO; GO:0003208; P:cardiac ventricle morphogenesis; IMP:ZFIN.
DR   GO; GO:0098609; P:cell-cell adhesion; IMP:ZFIN.
DR   GO; GO:0021536; P:diencephalon development; IMP:ZFIN.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; IMP:ZFIN.
DR   GO; GO:0021979; P:hypothalamus cell differentiation; IMP:ZFIN.
DR   GO; GO:0072576; P:liver morphogenesis; IMP:ZFIN.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IPI:ZFIN.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   GO; GO:0048798; P:swim bladder inflation; IMP:ZFIN.
DR   GO; GO:0021591; P:ventricular system development; IMP:ZFIN.
DR   CDD; cd00130; PAS; 2.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR001067; Nuc_translocat.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR013767; PAS_fold.
DR   Pfam; PF00010; HLH; 1.
DR   Pfam; PF00989; PAS; 1.
DR   PRINTS; PR00785; NCTRNSLOCATR.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00086; PAC; 1.
DR   SMART; SM00091; PAS; 2.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   SUPFAM; SSF55785; SSF55785; 2.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS50112; PAS; 2.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; DNA-binding; Nucleus; Reference proteome;
KW   Repeat; Repressor; Transcription; Transcription regulation.
FT   CHAIN           1..737
FT                   /note="Aryl hydrocarbon receptor nuclear translocator 2"
FT                   /id="PRO_0000239938"
FT   DOMAIN          78..131
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   DOMAIN          149..221
FT                   /note="PAS 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          340..406
FT                   /note="PAS 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          413..456
FT                   /note="PAC"
FT                   /evidence="ECO:0000255"
FT   REGION          1..73
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          525..556
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          588..721
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        46..73
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        588..704
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         66..80
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11072074"
FT                   /id="VSP_052058"
FT   VAR_SEQ         405..425
FT                   /note="VKLKGQVLSVMYRFRMKNREW -> RQNQIKPVSQHQSHISHMMFF (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10960127,
FT                   ECO:0000303|PubMed:11072074"
FT                   /id="VSP_052059"
FT   VAR_SEQ         426..737
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10960127,
FT                   ECO:0000303|PubMed:11072074"
FT                   /id="VSP_052060"
FT   CONFLICT        137
FT                   /note="T -> A (in Ref. 1; AAG25920)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        370
FT                   /note="I -> T (in Ref. 1; AAG25920)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        379
FT                   /note="D -> V (in Ref. 2; AAF73280)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        438
FT                   /note="P -> S (in Ref. 1; AAG25921)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        495
FT                   /note="T -> S (in Ref. 1; AAG25921)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        625
FT                   /note="A -> V (in Ref. 1; AAG25921)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   737 AA;  80972 MW;  96CB457F52B12F09 CRC64;
     MATPAAVNPS EMGTDLPGPV SMPGAVVGAG QVRMTGAMPG RGGKRRSAGM DFDDEDGEGP
     SKFSRYDDDQ IPGDKERYAR ENHSEIERRR RNKMTQYITE LSDMVPTCSA LARKPDKLTI
     LRMAVSHMKS MRGTGNTSTD GAYKPSFLTE QELKHLILEA ADGFLFVVAA ETGRVIYVSD
     SVTPVLNHPQ SEWFGSTLFE QVHPDDVDKL REQLSTSENS MTGRILDLKT GTVKKEGQQS
     SMRMCMGSRR SFICRMRCGS APLDHISLNR LSSMRKRYRN GLGPSKEGEA QYSVVHCTGY
     IKAWPPAGMT IPDEDTEAGQ TSKYCLVAIG RLQVTSSPVS MDMNGLSVPT EFLSRHNSDG
     IITFVDPRCI NVIGYQPQDL LGKDILEFCH PEDQSHLRES FQQVVKLKGQ VLSVMYRFRM
     KNREWMLIRT SSFTFQNPYS DEIEYIICTN TNVKQLQQQQ QAELEVHQRD GLTAYDLSQV
     PVSGVSAGVH ESGKTIDKTE SLFSQERDPR FSDIYTGIST SEKKMMVPSS TSGGQQLYSQ
     GSPFQPGHSG KSFSSSVIHV PGVNDIQSTA GSAGQNLSQI SRQINTGQVS WSGNRPPFSG
     QQIPAQSNKA QSSPFGIGSS HSYQADPSSY SPLSSPATSS PSGNAYSNLA NRNTAFDVSG
     ESSQSGGQFQ GRPSEVWSQW QSQHHSQQAG DPHPHTQASQ TEVFQDMLPM PGDPTQGTTN
     YNIEDFADLG MFPPFSE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025